share_log

Covetrus Will Own 50.01% of Joint Venture>CVET

Covetrus Will Own 50.01% of Joint Venture>CVET

Covetrus將擁有合資企業>CVeT 50.01%的股份
道琼斯 ·  2020/01/15 05:10

Press Release: Covetrus Enters Into Definitive Agreement to Divest scil animal care to Heska

新聞稿:Covetrus達成最終協議,將Small動物護理業務剝離給Heska

Covetrus Enters Into Definitive Agreement to Divest scil animal care to Heska

Covetrus達成最終協議,將Scan動物護理業務剝離給Heska


PORTLAND, Maine--(BUSINESS WIRE)--January 14, 2020--

緬因州波特蘭--(美國商業新聞網)--2020年1月14日--

Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today announced that it has entered into a definitive agreement to sell its scil animal care business ("scil") to Heska Corporation ("Heska") (NASDAQ: HSKA) for a purchase price of $125 million in cash, subject to customary closing adjustments.

全球領先的動物保健技術和服務供應商Covetrus(納斯達克股票代碼:CVET)今天宣佈,該公司已達成一項最終協議,將以1.25億美元現金的收購價向赫斯卡公司(Heska Corporation)出售其動物護理業務(“SCEL”)。

The transaction is expected to close in the next 60 to 90 days, subject to customary closing conditions. Covetrus expects that net cash proceeds from the transaction, after taxes and deal-related fees, will help to reduce its net debt and to improve its leverage position. The proceeds may also be used for other general corporate purposes.

根據慣例的成交條件,這筆交易預計將在未來60至90天內完成。Covetrus預計,扣除税後和交易相關費用後,這筆交易的淨現金收益將有助於減少其淨債務,並改善其槓桿狀況。所得款項亦可用於其他一般企業用途。

"While we are still in the early stages of executing on our strategy, this transaction is an important initial step in that process," said Ben Wolin, Covetrus acting president and chief executive officer.

Covetrus代理總裁兼首席執行官本·沃林(Ben Wolin)表示:“雖然我們仍處於執行我們戰略的早期階段,但這筆交易是這一過程中重要的第一步。”

The definitive agreement also includes a commercial relationship between Covetrus and Heska tied to ongoing logistics support for Heska's family of diagnostic products as well as connectivity between the Covetrus Global Technology Solutions practice information management software systems ("PIMS") and Heska's laboratory and imaging solutions.

最終協議還包括Covetrus和Heska之間的商業關係,這些關係涉及對Heska診斷產品系列的持續物流支持,以及Covetrus全球技術解決方案實踐信息管理軟件系統(“PIMS”)與Heska實驗室和成像解決方案之間的連接。

Stifel acted as the exclusive financial advisor to Covetrus for this transaction.

Stifel在這筆交易中擔任Covetrus的獨家財務顧問。

Separately, Covetrus announced today an agreement to combine the company's Spain and Portugal businesses with Distrivet, the leading provider of veterinary products and services in Spain. This new joint venture brings together two highly complementary businesses in the attractive Spanish market. Covetrus will own 50.01% of Distrivet, a Covetrus company, and the joint venture will be treated as an investment under the equity method of accounting. The transaction is expected to close in approximately 90 days, subject to satisfaction of customary closing conditions including regulatory clearance. Financial terms were not disclosed.

另外,Covetrus今天宣佈了一項協議,將該公司在西班牙和葡萄牙的業務與西班牙領先的獸醫產品和服務提供商Distrivet合併。這家新的合資企業在富有吸引力的西班牙市場將兩項互補性很強的業務合併在一起。Covetrus將擁有Covetrus旗下公司Distrive50.01%的股份,根據股權會計方法,合資公司將被視為一項投資。這筆交易預計將在大約90天內完成,前提是滿足包括監管許可在內的慣常完成條件。財務條款沒有披露。

About Covetrus

關於Covetrus

Covetrus is a global animal-health technology and services company dedicated to empowering veterinary practice partners to drive improved health and financial outcomes. We're bringing together products, services, and technology into a single platform that connects our customers to the solutions and insights they need to work best. Our passion for the well-being of animals and those who care for them drives us to advance the world of veterinary medicine. Covetrus is headquartered in Portland, Maine, with more than 5,500 employees, serving over 100,000 customers around the globe. Learn more at covetrus.com.

Covetrus是一家全球動物健康技術和服務公司,致力於增強獸醫實踐合作伙伴的能力,以推動改善健康和財務結果。我們將產品、服務和技術整合到一個平台中,將我們的客户與他們最佳工作所需的解決方案和洞察力連接起來。我們對動物福祉和那些關心它們的人的熱情驅使我們推動獸醫世界的發展。Covetrus總部設在緬因州波特蘭,擁有5500多名員工,為全球10萬多家客户提供服務。請訪問covetrus.com瞭解更多信息。

Forward-Looking Statements

前瞻性陳述

This press release contains certain statements that are forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and that involve risks and uncertainties, including statements about the timing for closing the transactions described herein, our expectations regarding the use of proceeds from the transaction, the benefits of the transactions, our execution on our strategy and the steps we have taken in pursuit of our goals. We may, in some cases use terms such as "predicts," "believes," "potential," "continue," "anticipates," "estimates," "expects," "plans," "intends," "may," "could, " "might," "likely," "will," "should" or other words that convey uncertainty of the future events or outcomes to identify these forward-looking statements. Such statements are subject to numerous risks and uncertainties, including but not limited to, our ability to close the transactions; the impact of the transactions on our financial position and our customers; risks associated with our management transition; the ability to successfully integrate operations and employees; the ability to realize anticipated benefits and synergies of the transactions that created Covetrus; the potential impact of the consummation of the transactions on relationships, including with employees, customers and competitors; the ability to retain key personnel; the ability to achieve performance targets; changes in financial markets, interest rates and foreign currency exchange rates; changes in our market; the impact of litigation; the impact of Brexit; and those additional risks and factors discussed, including those discussed under the heading "Risk Factors" in our Annual Report on Form 10-K filed on March 29, 2019 and Quarterly Report on Form 10-Q filed for the quarter ended September 30, 2019, and in our other SEC filings. Our forward-looking statements are based on current beliefs and expectations of our management team and, except as required by law, we undertake no obligations to make any revisions to the forward-looking statements contained in this release or to update them to reflect events or circumstances occurring after the date of this release, whether as a result of new information, future developments or otherwise. Investors are cautioned not to place undue reliance on these forward-looking statements.

本新聞稿包含符合1933年“證券法”(修訂本)第27A節和1934年“證券交易法”(修訂本)第21E節定義的前瞻性陳述。這些陳述涉及風險和不確定因素,包括有關完成本文所述交易的時間、我們對交易收益的使用的預期、交易的好處、我們執行我們的戰略以及我們為實現我們的目標所採取的步驟。在某些情況下,我們可能會使用“預測”、“相信”、“潛在”、“繼續”、“預期”、“估計”、“預期”、“計劃”、“打算”、“可能”、“將會”、“應該”或其他表達未來事件或結果不確定性的詞語來識別這些前瞻性陳述。這類陳述會受到許多風險和不確定性的影響,包括但不限於:我們完成交易的能力;交易對我們的財務狀況和客户的影響;與我們的管理層過渡相關的風險;成功整合業務和員工的能力;實現創建Covetrus的交易的預期效益和協同效應的能力;完成交易對關係的潛在影響,包括與員工、客户和競爭對手的關係;留住關鍵人員的能力;實現業績目標的能力;金融市場、利率和外匯匯率的變化;英國退歐的影響;以及討論的其他風險和因素,包括我們在2019年3月29日提交的Form 10-K年度報告和截至2019年9月30日的季度Form 10-Q季度報告中以“風險因素”標題討論的風險和因素, 在我們提交給美國證券交易委員會的其他文件中。我們的前瞻性陳述是基於我們管理團隊目前的信念和期望,除非法律要求,否則我們沒有義務對本新聞稿中包含的前瞻性陳述進行任何修改或更新,以反映本新聞稿發佈之日之後發生的事件或情況,無論是由於新信息、未來發展還是其他原因。告誡投資者不要過度依賴這些前瞻性陳述。

View source version on businesswire.com: https://www.businesswire.com/news/home/20200114005828/en/

在business wire.com上查看源代碼版本:https://www.businesswire.com/news/home/20200114005828/en/



CONTACT: Nicholas Jansen | Investor Relations

聯繫人:尼古拉斯·詹森(Nicholas Jansen)|投資者關係部

nicholas.jansen@covetrus.com | (207) 550-8106

郵箱:nicholas.jansen@covetrus.com|(207)550-8106

Kiní Schoop | Public Relations

基尼·斯庫普|公共關係

kini.schoop@covetrus.com | (207) 550-8018

郵箱:kini.Schoop@covetrus.com|(207)550-8018




(END) Dow Jones Newswires

(完)道瓊通訊社

January 14, 2020 16:09 ET (21:09 GMT)

2020年1月14日東部時間16:09(格林尼治標準時間21:09)

*DJ Covetrus to Combine Spain and Portugal Ops With Distrivet, Forming Joint Venture

*DJ Covetrus將西班牙和葡萄牙Ops與Distriette合併,成立合資企業



(MORE TO FOLLOW) Dow Jones Newswires (212-416-2800)

(更多信息)道瓊斯通訊社(212-416-2800)

January 14, 2020 16:10 ET (21:10 GMT)

2020年1月14日美國東部時間16:10(格林尼治標準時間21:10)

*DJ Covetrus Will Own 50.01% of Joint Venture>CVET

*DJ Covetrus將擁有合資企業>CVeT 50.01%的股份



(MORE TO FOLLOW) Dow Jones Newswires (212-416-2800)

(更多信息)道瓊斯通訊社(212-416-2800)

January 14, 2020 16:10 ET (21:10 GMT)

2020年1月14日美國東部時間16:10(格林尼治標準時間21:10)

Copyright (c) 2020 Dow Jones & Company, Inc.

版權所有(C)2020道瓊斯公司。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論